Literature DB >> 19691924

The efficacy of ustekinumab on the articular and dermatologic manifestations of psoriatic arthritis.

Arthur Kavanaugh1.   

Abstract

Entities:  

Year:  2009        PMID： 19691924     DOI： 10.1007/s11926-009-0043-z

Source DB:  PubMed          Journal:  Curr Rheumatol Rep        ISSN： 1523-3774            Impact factor:   4.592


× No keyword cloud information.
  7 in total

Review 1.  Current concepts in psoriatic arthritis.

Authors:  Dafna D Gladman
Journal:  Curr Opin Rheumatol       Date:  2002-07       Impact factor: 5.006

2.  Adalimumab for the treatment of patients with moderately to severely active psoriatic arthritis: results of a double-blind, randomized, placebo-controlled trial.

Authors:  Philip J Mease; Dafna D Gladman; Christopher T Ritchlin; Eric M Ruderman; Serge D Steinfeld; Ernest H S Choy; John T Sharp; Peter A Ory; Renee J Perdok; Mark A Weinberg
Journal:  Arthritis Rheum       Date:  2005-10

3.  Infliximab improves signs and symptoms of psoriatic arthritis: results of the IMPACT 2 trial.

Authors:  C Antoni; G G Krueger; K de Vlam; C Birbara; A Beutler; C Guzzo; B Zhou; L T Dooley; A Kavanaugh
Journal:  Ann Rheum Dis       Date:  2005-01-27       Impact factor: 19.103

4.  Progression of peripheral joint disease in psoriatic arthritis: a 5-yr prospective study.

Authors:  N J McHugh; C Balachrishnan; S M Jones
Journal:  Rheumatology (Oxford)       Date:  2003-03-14       Impact factor: 7.580

5.  Etanercept treatment of psoriatic arthritis: safety, efficacy, and effect on disease progression.

Authors:  Philip J Mease; Alan J Kivitz; Francis X Burch; Evan L Siegel; Stanley B Cohen; Peter Ory; David Salonen; Joel Rubenstein; John T Sharp; Wayne Tsuji
Journal:  Arthritis Rheum       Date:  2004-07

6.  A human interleukin-12/23 monoclonal antibody for the treatment of psoriasis.

Authors:  Gerald G Krueger; Richard G Langley; Craig Leonardi; Newman Yeilding; Cynthia Guzzo; Yuhua Wang; Lisa T Dooley; Mark Lebwohl
Journal:  N Engl J Med       Date:  2007-02-08       Impact factor: 91.245

7.  Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 76-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 1).

Authors:  Craig L Leonardi; Alexa B Kimball; Kim A Papp; Newman Yeilding; Cynthia Guzzo; Yuhua Wang; Shu Li; Lisa T Dooley; Kenneth B Gordon
Journal:  Lancet       Date:  2008-05-17       Impact factor: 79.321
  7 in total
  4 in total

Review 1.  Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.

Authors:  Emilie Sbidian; Anna Chaimani; Ignacio Garcia-Doval; Giao Do; Camille Hua; Canelle Mazaud; Catherine Droitcourt; Carolyn Hughes; John R Ingram; Luigi Naldi; Olivier Chosidow; Laurence Le Cleach
Journal:  Cochrane Database Syst Rev       Date:  2017-12-22

Review 2.  Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.

Authors:  Emilie Sbidian; Anna Chaimani; Ignacio Garcia-Doval; Liz Doney; Corinna Dressler; Camille Hua; Carolyn Hughes; Luigi Naldi; Sivem Afach; Laurence Le Cleach
Journal:  Cochrane Database Syst Rev       Date:  2022-05-23

3.  Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.

Authors:  Emilie Sbidian; Anna Chaimani; Ignacio Garcia-Doval; Liz Doney; Corinna Dressler; Camille Hua; Carolyn Hughes; Luigi Naldi; Sivem Afach; Laurence Le Cleach
Journal:  Cochrane Database Syst Rev       Date:  2021-04-19

4.  Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.

Authors:  Emilie Sbidian; Anna Chaimani; Sivem Afach; Liz Doney; Corinna Dressler; Camille Hua; Canelle Mazaud; Céline Phan; Carolyn Hughes; Dru Riddle; Luigi Naldi; Ignacio Garcia-Doval; Laurence Le Cleach
Journal:  Cochrane Database Syst Rev       Date:  2020-01-09
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.